Zentiva RamiLich comp

RamiLich comp is a combination medication containing Ramipril and Hydrochlorothiazide, used primarily for treating hypertension. The brand Zentiva has a rich European history, originating in the Czech Republic. It became a prominent name in the pharmaceutical industry following the merger of Czech company Léčiva and Slovak company Slovakofarma.

While Zentiva was previously owned by the French pharmaceutical giant Sanofi, it was acquired by the private equity firm Advent International in 2018. Today, Zentiva operates as an independent European company with a diversified manufacturing network. Its products are manufactured across various European sites, primarily in the Czech Republic (Prague), Romania (Bucharest), and often under contract in other EU locations to serve the German market.